http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104171921-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L7-109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L7-109
filingDate 2014-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104171921-B
titleOfInvention Special low albumen noodles of diabetic nephropathy patients undergoing and preparation method thereof
abstract The present invention relates to noodles technical field, particularly to a kind of special low albumen noodles of diabetic nephropathy patients undergoing: 0 30 parts of flour, α modified starch 0 30 parts, wheaten starch 40 100 parts, golden needle fungus or wheat bran 18 parts, sodium carboxymethyl cellulose 0.1 0.3 parts, 0.1 0.3 parts of carbonate, phosphate 0.01 0.08 parts, 58 parts of medicine food dual purpose plant powder.Product protein content is less than 4g/100g, calculates according to the daily ingestion of 500g of diabetic nephropathy patient, and non-prime albumen intake is less than 20g, meets its nutritional requirement;By adding appropriate golden needle fungus, Testa Tritici etc., significantly reduce the glycaemic index of product, Diabetic Nephropathy Patients carbohydrate metabolism is had certain regulation effect;Add medicine food dual purpose plant powder, utilize the antioxidant activity of polyphenol isoreactivity material therein, reduce diabetic nephropathy patient vivo oxidation stress level, there is certain adjuvant treatment effect.
priorityDate 2014-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452546156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817

Total number of triples: 37.